iSpecimen Inc. (NASDAQ:ISPC) Sees Large Increase in Short Interest

iSpecimen Inc. (NASDAQ:ISPC) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totalling 788,000 shares, an increase of 149.8% from the June 30th total of 315,400 shares. Based on an average trading volume of 4,240,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 7.9% of the shares of the stock are short sold.

iSpecimen Stock Performance

Shares of NASDAQ ISPC opened at $0.28 on Friday. iSpecimen has a twelve month low of $0.20 and a twelve month high of $1.75. The firm has a 50-day moving average of $0.33 and a two-hundred day moving average of $0.35. The company has a market capitalization of $3.71 million, a price-to-earnings ratio of -0.22 and a beta of 1.60.

iSpecimen (NASDAQ:ISPC) last issued its earnings results on Tuesday, May 7th. The company reported ($0.32) earnings per share for the quarter. The business had revenue of $2.29 million for the quarter. iSpecimen had a negative return on equity of 105.25% and a negative net margin of 124.84%.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.